Use of oral ketamine by academic Hospitals in the US

Annals of Pharmacotherapy

Volumn 47, Issue 4, 2013, Pages 591-

  Hatton, Randy C ^a   Patel, Jaymini ^b   Low, May Wen ^b   Ganesh, Omjoy ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF BATH   (United Kingdom)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ANXIETY DISORDER; BITTER TASTE; CROSS-SECTIONAL STUDY; DEPRESSION; DILUTION; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG STABILITY; DRUG UTILIZATION; HEALTH SURVEY; HOSPICE CARE; HUMAN; LETTER; LIQUID; PAIN; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADMINISTRATION, ORAL; ANESTHETICS, DISSOCIATIVE; CROSS-SECTIONAL STUDIES; HUMANS; KETAMINE; UNITED STATES;

EID: 84876209059     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1S019     Document Type: Letter

References (11)

1. Haines DR, Gaines SP. N of 1 randomised controlled trials of ketamine in patients with chronic pain. Pain 1999;83:283-7. doi: 10.1016/S0304-3959(99)00117-7
2. Eide PK, Stubhaug A. Relief of glossopharyngeal neuralgia by ketamine-induced n-methyl-aspartate receptor blockade. Neurosurgery 1997;41:505-8. doi: 10.1097/00006123-199708000-00043
3. Soto E, Stewart DR, Mannes AJ, Ruppert SL, et al. Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 glomus tumor-associated complex regional pain syndrome. Am J Hosp Palliat Care 2012;29:308-17. doi: 10.1177/1049909111416345
4. McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospital with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe renal insufficiency: a case report. Int J Pharm Compound 2012;16:364-8.
5. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989;36:186-97. doi: 10.1007/BF03011442
6. Ketamine. In: DRUGDEX System. Greenwood Village, CO: Truven Healthcare. Updated periodically (accessed 2012 Dec 28).
7. Ketamine. In: Twycross R, Wilcock A, eds. 13: Anaesthesia. PCF4+: palliative care formulary. pdf version, September 2012. Palliativedrugs. com Ltd: Nottingham, England, 2012:755-63.
8. McMullen L. U.S. News ranks best hospitals 2012-13. July 16, 2012. http:// health.usnews.com/health-news/best-hospitals/articles/2012/07/16/us-newsranks-best-hospitals-2012-13 (accessed 2012 Oct 18).
9. Code of Federal Regulations. Title 21 Food and Drugs, Chapter I, Food and Drug Administration, Department of Health and Human Services, Subchapter C-Drugs: General, Part 216 Pharmacy Compounding, Subpart B Compounded Drug Products. §216.24 Drug products withdrawn or removed from the market for reasons of safety or effectiveness.
10. Pharmaceutical compounding-nonsterile preparations. Stability criteria and beyond-use dating (Chapter 795). In: US Pharmacopoeia 35. Rockville MD: United States Pharmacopeial Convention, 2012:348.
11. Morgan AJ, Dutkiewicz TWS. Oral ketamine (letter). Anaesthesia 1983; 38:293. doi: 10.1111/j.1365-2044.1983.tb14006.